What happened
Osang Healthcare disclosed a supply contract with HemoCue AB, worth US$4.4M, about 5.1% of its recent annual revenue, running through Nov 2026.
For context, this single contract equals about 5.1% of the company's most recent annual revenue.
| Counterparty | HemoCue AB |
|---|---|
| Contract value | US$4.4M |
| vs. recent revenue | 5.1% |
| Through | Nov 2026 (from May 2026) |
| Filed | 2026-05-13, Supply contract signed (voluntary) |
| Source | DART rcept 20260513900560 → open original filing |
Source: DART. Information only, not investment advice.